AT355232B - METHOD FOR PRODUCING NEW STEROIDS OF THE PREGNAN OR 19-NORPREGNAN SERIES - Google Patents

METHOD FOR PRODUCING NEW STEROIDS OF THE PREGNAN OR 19-NORPREGNAN SERIES

Info

Publication number
AT355232B
AT355232B AT395173A AT395173A AT355232B AT 355232 B AT355232 B AT 355232B AT 395173 A AT395173 A AT 395173A AT 395173 A AT395173 A AT 395173A AT 355232 B AT355232 B AT 355232B
Authority
AT
Austria
Prior art keywords
norpregnan
pregnan
series
producing new
new steroids
Prior art date
Application number
AT395173A
Other languages
German (de)
Other versions
ATA395173A (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of ATA395173A publication Critical patent/ATA395173A/en
Application granted granted Critical
Publication of AT355232B publication Critical patent/AT355232B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
AT395173A 1972-05-05 1973-05-04 METHOD FOR PRODUCING NEW STEROIDS OF THE PREGNAN OR 19-NORPREGNAN SERIES AT355232B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (2)

Publication Number Publication Date
ATA395173A ATA395173A (en) 1979-07-15
AT355232B true AT355232B (en) 1980-02-25

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT395173A AT355232B (en) 1972-05-05 1973-05-04 METHOD FOR PRODUCING NEW STEROIDS OF THE PREGNAN OR 19-NORPREGNAN SERIES

Country Status (16)

Country Link
JP (1) JPS4961150A (en)
AT (1) AT355232B (en)
AU (1) AU475168B2 (en)
BE (1) BE799102A (en)
CA (1) CA1013341A (en)
CH (1) CH617710A5 (en)
DE (1) DE2322532A1 (en)
ES (1) ES414411A1 (en)
FR (1) FR2183792B1 (en)
GB (1) GB1430942A (en)
IE (1) IE37596B1 (en)
IL (1) IL42196A (en)
LU (1) LU67546A1 (en)
NL (1) NL7306234A (en)
SE (1) SE400771B (en)
ZA (1) ZA733035B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
DK1038880T3 (en) * 1994-02-14 2008-03-03 Euro Celtique Sa Androstans and pregnans for allosteric modulation of GABA receptor
US5939545A (en) 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
GR1003861B (en) * 2000-12-29 2002-04-11 Novel gabaa modulating neurosteroids
JP4915427B2 (en) * 2009-03-30 2012-04-11 ブラザー工業株式会社 Liquid supply joint, liquid discharge head and recording apparatus using the same
EP2766380B1 (en) 2011-10-14 2019-04-24 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
PT2806877T (en) 2012-01-23 2019-12-06 Sage Therapeutics Inc Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
PT2986624T (en) 2013-04-17 2020-07-07 Sage Therapeutics Inc 19-nor neuroactive steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
PT3498725T (en) 2013-04-17 2021-09-09 Sage Therapeutics Inc 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid for use in therapy
CN105555277B (en) 2013-07-19 2022-01-11 萨奇治疗股份有限公司 Neuroactive steroid compounds, compositions and uses thereof
RU2696585C2 (en) 2013-08-23 2019-08-05 Сейдж Терапьютикс, Инк. Neuroactive steroids, compositions and use thereof
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
RS60642B1 (en) 2014-10-16 2020-09-30 Sage Therapeutics Inc Compositions and methods for treating cns disorders
WO2016061527A1 (en) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
RS60343B1 (en) 2014-11-27 2020-07-31 Sage Therapeutics Inc Compositions and methods for treating cns disorders
DK3250210T3 (en) 2015-01-26 2021-03-08 Sage Therapeutics Inc COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
ES2935476T3 (en) 2015-02-20 2023-03-07 Sage Therapeutics Inc Neuroactive steroids, compositions and uses thereof
MA43815A (en) 2016-03-08 2021-04-07 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS, AND THEIR USES
CA3030420A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
MA45599A (en) 2016-07-11 2019-05-15 Sage Therapeutics Inc NEUROACTIVE STEROIDS SUBSTITUTED FOR C17, C20 AND C21 AND THEIR USE PROCEDURES
MA56046A (en) 2019-05-31 2022-04-06 Sage Therapeutics Inc NEUROACTIVE STEROIDS AND ASSOCIATED COMPOSITIONS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (en) * 1962-09-14 1963-12-20 Roussel Uclaf New process for the preparation of 21-amino steroids
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
AU475168B2 (en) 1976-08-12
AU5528473A (en) 1974-11-07
SE400771B (en) 1978-04-10
CA1013341A (en) 1977-07-05
CH617710A5 (en) 1980-06-13
ZA733035B (en) 1974-04-24
IE37596B1 (en) 1977-08-31
DE2322532A1 (en) 1973-11-22
JPS4961150A (en) 1974-06-13
BE799102A (en) 1973-11-05
FR2183792B1 (en) 1977-07-15
FR2183792A1 (en) 1973-12-21
NL7306234A (en) 1973-11-07
IL42196A (en) 1978-10-31
IL42196A0 (en) 1973-07-30
ATA395173A (en) 1979-07-15
LU67546A1 (en) 1973-07-13
GB1430942A (en) 1976-04-07
ES414411A1 (en) 1976-02-01
IE37596L (en) 1973-11-05

Similar Documents

Publication Publication Date Title
AT355232B (en) METHOD FOR PRODUCING NEW STEROIDS OF THE PREGNAN OR 19-NORPREGNAN SERIES
AT341684B (en) METHOD FOR PRODUCING THE NEW TRI-P-TOLUOLSULFONATE OF S-ADENOSYL -L-METHIONINE
AT356809B (en) METHOD FOR PRODUCING NEW ENOL DERIVATIVES
AT329203B (en) METHOD FOR PRODUCING NEW HEPTAPEPTIDS
AT329076B (en) PROCESS FOR THE PREPARATION OF NEW 1-AMINOURACILS
ATA583473A (en) METHOD FOR PRODUCING NEW SUFONAMIDODIPHENYLATHERS
AT323339B (en) METHOD FOR PRODUCING NEW BENZOMORPHANES
ATA770674A (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT324312B (en) PROCESS FOR THE PREPARATION OF NEW TRIFLUOROMETHYLSALICYLANILIDES
AT329177B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT325774B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT325767B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT303983B (en) Process for the production of new 17-chloro steroids
AT326268B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT328078B (en) PROCESS FOR PRODUCING NEW CYANOMETHYLTHIOACETYLCEPHALOSPORINES
AT324333B (en) PROCESS FOR THE PREPARATION OF NEW SUBSTITUTED 5-CHROMANOLS
AT323750B (en) PROCESS FOR THE PREPARATION OF NEW NITROIMIDAZOLYL-TRIAZOLIC-PYRIDAZINES
AT324561B (en) METHOD OF MANUFACTURING NEW PENICILLINES
AT311567B (en) Process for the manufacture of new steroids
AT316747B (en) Process for the preparation of new alkyl-7-deoxy-7-mercaptoalkylthio-α-thiolincosaminides
AT315166B (en) Process for the preparation of new 2-acyl-5-nitrothiazoles
AT322104B (en) PROCESS FOR PRODUCING NEW PYRONO-RIFAMYCINES
AT324298B (en) METHOD FOR PRODUCING NEW SUBSTITUTED BICYCLOALKENONS
AT314748B (en) METHOD FOR PRODUCING NEW 16-METHYLENE-9BETA-10ALPHA-STEROIDS
AT312828B (en) Process for the manufacture of new steroids

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee